You are here: Industry Insights > Market News > COVID-19 vaccines will not be mandatory: WHO

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

water filter

WATER FILTER FOR WATER PURIFIER

DUST BAG

Small dust filter

HUMIDIFIER FILTER

Oil fume adsorption filter

COVID-19 vaccines will not be mandatory: WHO

expresspharmaDecember 09, 2020

Tag: COVID-19 vaccine , WHO , vaccination

Favorites

The World Health Organization does not foresee countries making it mandatory for citizens to take the new COVID-19 vaccines which have been developed, an official said.

“I don’t think we envisage any countries creating a mandate for vaccinations,” Kate O’Brien, WHO’s director of immunisation vaccines and biologicals, told a news conference.

“There may be some countries or some situations in countries where professional circumstances require it or highly recommend to be vaccinated,” she added, saying hospitals might be one such instance.

Previous:Preparing the pharma sector for the post-COVID world

Next:Aesthetic injectables market in APAC to reach $3.8 billion in 2030: GlobalData

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

COVID-19 vaccines will not be mandatory: WHO | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Wholesale Price Paeonia Lactiflora Extract

Whole Pure Natural Organic Bulk 98% Semen Plantaginis 95% Wholesale Fiber Seed Plantain Extract Psyl

Hot selling Wholesale bulk price Cosmetic grade Lauramidopropyl betaine CAS 4292-10-8

Wholesale Food Grade Free Sample Camellia Sinensis Extract Tea Saponin Powder

Private Label Herbal Supplements Wholesale Moringa Extract Freeze Dried Organic Price Bulk Leaf Mori

Wholesale Skin Whitening Cosmetic Grade L-glutathione Powder L glutathione Reduced Powder

Wholesale Bulk 10% 20% 30% Turkey Tail Extract Polysaccharides Certified Organic Turkey Tail Mushroo

Factory Supply Wholesale Free Sample Bulk Pure Natural Chinese Traditional Herb Root Siberian Ginsen

High Quality Food Grade Piperine Wholesale Natural Black Pepper Extract Powder 95% 98% Piperine

Wholesale Price Premium Pumpkin Seed Gummy

COVID-19 vaccines will not be mandatory: WHO

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may likeMore>>

You may like
More>>